Last reviewed · How we verify

NCT06117098

Mobile App for Risk Reduction of Type 2 Diabetes

Status unknown NA Last updated 3 November 2023
What this trial tests

NA trial testing Mobile application in Prediabetic State in 60 participants. Status unknown.

Timeline
2 May 2023
Primary endpoint
31 December 2023
30 June 2024

Quick facts

Lead sponsorOslo Metropolitan University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment60
Start date2 May 2023
Primary completion31 December 2023
Estimated completion30 June 2024
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo Metropolitan University

Who can join

18 and older, any sex, with Prediabetic State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this feasibility study is to investigate whether a full scale RCT on the efficacy of a mobile app for risk reduction on type 2 diabetes can be conducted in the way it is planned or whether it needs to be modified. This will be investigated through a feasibility study (small scale RCT) on the efficacy of mobile technology on risk reduction of type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mobile Phone App to Promote Lifestyle Change in People at Risk of Type 2 Diabetes: Feasibility 3-Arm Randomized Controlled Trial.
    Skoglund G, Hilde G, Lunde P, Cruz Naceno VV, et al · · 2025 · PMID 39864814 · DOI 10.2196/63737

Verify or expand the search:

Other trials of Mobile application

Trials testing the same drug.

Other recruiting trials for Prediabetic State

Currently open trials in the same condition.

Other Oslo Metropolitan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing